Vicore Pharma Holding AB
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VCRE research report →
Range $25 – $25
Price Chart
About the company
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
- CEO
- Ahmed S. Mousa
- IPO
- 2026
- Employees
- 37
- HQ
- Stockholm, AB, SE
Get TickerSpark's AI analysis on VCRE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $265.67M
- P/E
- -5.52
- PEG
- -0.35
- P/S
- 763.71
- P/B
- 4.04
- EV/EBITDA
- -4.47
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -14161.60%
- Net Margin
- -13397.10%
- ROE
- -55.97%
- ROIC
- -74.47%
Latest fiscal year · YoY change
- Revenue
- $3.82M-96.5%
- Gross Profit
- $3.82M-96.5%
- Op Income
- $-454,445,000
- Net Income
- $-477,474,000-183.1%
- EPS
- $-2.20-100.0%
- OCF Growth
- -127.8%
- FCF Growth
- -127.8%
- 52W High
- $17.80
- 52W Low
- $7.88
- 50D MA
- $9.80
- 200D MA
- $10.90
- Beta
- 0.15
- RSI (14)
- 42
- Avg Volume
- 23.18K
No earnings-call transcripts are available for VCRE yet.
- Free Float
- 71.1%
- Shares Outstanding
- 28.25M
- Float Shares
- 20.09M
Our VCRE coverage
Recent articles, reports, and earnings notes.
Want a deeper read on VCRE?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Vicore Pharma to Participate in the Chardan Healthcare Conference
accessnewswire.com · Oct 13
Increase in Number of Shares and Votes in Vicore Pharma
accessnewswire.com · Sep 30
Vicore Pharma to Present in The Stifel 2026 Virtual Immunology and Inflammation Forum
accessnewswire.com · Sep 17
Vicore Pharma to Participate in Upcoming Healthcare Conferences
accessnewswire.com · Sep 1
Vicore Pharma to Present at the European Respiratory Society Congress 2026
accessnewswire.com · Aug 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
